Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain ; volume:12 ; number:1 ; day:15 ; month:7 ; year:2024 ; pages:1 ; date:12.2024
Acta Neuropathologica Communications ; 12, Heft 1 (15.7.2024), 1, 12.2024

Creator: Frey, Bryan
Holzinger, David
Taylor, Keenan
Ehrnhoefer, Dagmar E.
Striebinger, Andreas
Biesinger, Sandra
Gasparini, Laura
O’Neill, Michael J.
Wegner, Florian
Barghorn, Stefan
Höglinger, Günter U.
Heym, Roland G.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-024-01825-9

URN: urn:nbn:de:101:1-2410012059454.254307477438

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Frey, Bryan
Holzinger, David
Taylor, Keenan
Ehrnhoefer, Dagmar E.
Striebinger, Andreas
Biesinger, Sandra
Gasparini, Laura
O’Neill, Michael J.
Wegner, Florian
Barghorn, Stefan
Höglinger, Günter U.
Heym, Roland G.
SpringerLink (Online service)

Other Objects (12)

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease

Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease

Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease

Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease

Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease

Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease

Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Related objects

Reset password